Leap Therapeutics Inc. buy melinda
Start price
25.04.17
/
50%
€67.56
Target price
05.05.17
€70.81
Performance (%)
5.74%
End price
05.05.17
€71.44
Summary
This prediction ended on 05.05.17 with a price of €71.44. The BUY prediction by melinda finished with a performance of 5.74%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Leap Therapeutics Inc. | 12.879% | 12.879% | -11.310% | -79.420% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by melinda for this prediction
In the thread Leap Therapeutics Inc diskutieren
Onkologie
Leap Therapeutics, Inc. engagiert in der klinischen Praktikum immuno-oncology.It in großer Wissenschaft investiert und gezielte Forschung schnell in High-Impact-Moleküle übersetzen wird therapeutics.The Firma Pipeline gebaut wird auf der Identifizierung und Entwicklung translationale stufige Moleküle in den Bereichen Zell
(Zielkurs erreicht)
Stopped prediction by melinda for Leap Therapeutics Inc.
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.40
27.09.20
27.09.20
€20.00
04.11.21
04.11.21
38.72%
05.11.21
05.11.21
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€55.92
15.10.18
15.10.18
€66.75
22.01.19
22.01.19
-46.77%
22.01.19
22.01.19